QuidelOrtho Corporation was removed from several Russell growth-focused benchmarks in late June 2026, including the Russell 3000 Growth, 2000 Growth, 2500 Growth, 3000E Growth, and Small Cap Comp Growth indexes. The company also appointed former Masimo finance chief Micah Young as its new Chief Financial Officer and principal financial officer, effective July 6, 2026. The index exclusions may add short-term share price and liquidity volatility, while Young's experience in finance and capital allocation at other medical technology companies could influence how aggressively QuidelOrtho pursues cost savings and balance sheet resilience. QuidelOrtho recently reported net losses and lowered its 2026 revenue guidance to between US$2.7 billion and US$2.75 billion.
Quidel CorporationRemoved from multiple Russell growth indexes and lowered 2026 revenue guidance, indicating financial weakness.
Masimo Corporation